Pyridine → Tert-butyl 4-[1-(2-fluorophenyl)-imidazol-4-yl]-1,2,3,6-tetrahydropyridine-1-carboxylate
Reaction equation
N1C=CC=CC=1.[NH:7]1[CH:11]=[C:10]([C:12]2[CH2:13][CH2:14][N:15]([C:18]([O:20][C:21]([CH3:24])([CH3:23])[CH3:22])=[O:19])[CH2:16][CH:17]=2)[N:9]=[CH:8]1.[F:25][C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][C:27]=1OB(O)O>ClCCl.C([O-])(=O)C.[Cu+2].C([O-])(=O)C>[F:25][C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][C:27]=1[N:7]1[CH:11]=[C:10]([C:12]2[CH2:13][CH2:14][N:15]([C:18]([O:20][C:21]([CH3:24])([CH3:23])[CH3:22])=[O:19])[CH2:16][CH:17]=2)[N:9]=[CH:8]1Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
Copper acetate (35 mg) and pyridine (0.02 ml) were added to a solution of 2 mg of the compound prepared in the above 3), i.e. tert-butyl 4-(1H-imidazol-4-yl)-3,6-dihydro-2H-pyridine-1-carboxylate and 35 mg of 2-fluorophenylboric acid in dichloromethane and the solution was stirred for three days. The solvent was evaporated in vacuo and the residue was separated and purified by a thin-layer chromatography (ethyl acetate/hexane=1/2) to give 2.48 mg of the title compound as a white solid.
Workup
- customThe solvent was evaporated in vacuo
- customthe residue was separated
- custompurified by a thin-layer chromatography (ethyl acetate/hexane=1/2)
Sources & evidence
- ORD record
- ord-6fab518853ea430890c082b2cd7c838a
- Source dataset
- uspto-grants-2010_12
- Patent number
- US07858800B2
Reaction notes
Loading…